Brinkmann, V. et al. Neutrophil extracellular traps kill bacteria. Science 303, 1532–1535 (2004).
Sorvillo, N. et al. Extracellular DNA NET-works with dire consequences for health. Circ. Res. 125, 470–488 (2019).
Albadawi, H. et al. Effect of DNase I treatment and neutrophil depletion on acute limb ischemia-reperfusion injury in mice. J. Vasc. Surg. 64, 484–493 (2016).
Ramacciotti, E. et al. P-selectin/PSGL-1 inhibitors versus enoxaparin in the resolution of venous thrombosis: a meta-analysis. Thromb. Res. 125, e138–e142 (2010).
Kim, K. et al. NOX2 is critical for heterotypic neutrophil-platelet interactions during vascular inflammation. Blood 126, 1952–1964 (2015).
Li, P. et al. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J. Exp. Med. 207, 1853–1862 (2010).
Cho, H. et al. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292, 1728–1731 (2001).
Ridker, P. M. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med. 377, 1119–1131 (2017).
Xu, L. et al. Heterobivalent ligands target cell-surface receptor combinations in vivo. Proc. Natl Acad. Sci. USA 109, 21295–21300 (2012).
Gunawan, R. C., Almeda, D. & Auguste, D. T. Complementary targeting of liposomes to IL-1α and TNF-α activated endothelial cells via the transient expression of VCAM1 and E-selectin. Biomaterials 32, 9848–9853 (2011).
Sapra, P. & Allen, T. M. Improved outcome when B-cell lymphoma is treated with combinations of immunoliposomal anticancer drugs targeted to both the CD19 and CD20 epitopes. Clin. Cancer Res. 10, 2530–2537 (2004).
Kanapathipillai, M., Brock, A. & Ingber, D. E. Nanoparticle targeting of anti-cancer drugs that alter intracellular signaling or influence the tumor microenvironment. Adv. Drug Deliv. Rev. 79, 107–118 (2014).
Anselmo, A. C. et al. Platelet-like nanoparticles: mimicking shape, flexibility, and surface biology of platelets to target vascular injuries. ACS Nano 8, 11243–11253 (2014).
Wang, Z. et al. Prevention of vascular inflammation by nanoparticle targeting of adherent neutrophils. Nat. Nanotechnol. 9, 204–210 (2014).
Chu, D. et al. Nanoparticle targeting of neutrophils for improved cancer immunotherapy. Adv. Healthc. Mater. 5, 1088–1093 (2016).
Robertson, J. D. et al. Targeting neutrophilic inflammation using polymersome-mediated cellular delivery. J. Immunol. 198, 3596–3604 (2017).
Liou, T. G. & Campbell, E. J. Nonisotropic enzyme–inhibitor interactions: a novel nonoxidative mechanism for quantum proteolysis by human neutrophils. Biochemistry 34, 16171–16177 (1995).
Owen, C. A. et al. Cell surface-bound elastase and cathepsin G on human neutrophils: a novel, non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteinases. J. Cell Biol. 131, 775–789 (1995).
Stenberg, P. E. et al. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J. Cell Biol. 101, 880–886 (1985).
Elliott, P. R. et al. Inhibitory conformation of the reactive loop of α1-antitrypsin. Nat. Struct. Biol. 3, 676–681 (1996).
Elliott, P. R. et al. Topography of a 2.0 Å structure of α1-antitrypsin reveals targets for rational drug design to prevent conformational disease. Protein Sci. 9, 1274–1281 (2000).
Forsyth, S., Horvath, A. & Coughlin, P. A review and comparison of the murine α1-antitrypsin and α1-antichymotrypsin multigene clusters with the human clade A serpins. Genomics 81, 336–345 (2003).
Gehrig, S., Mall, M. A. & Schultz, C. Spatially resolved monitoring of neutrophil elastase activity with ratiometric fluorescent reporters. Angew. Chem. Int. Ed. 51, 6258–6261 (2012).
Beatty, K., Bieth, J. & Travis, J. Kinetics of association of serine proteinases with native and oxidized α-1-proteinase inhibitor and α-1-antichymotrypsin. J. Biol. Chem. 255, 3931–3934 (1980).
Appeldoorn, C. C. et al. Rational optimization of a short human P-selectin-binding peptide leads to nanomolar affinity antagonists. J. Biol. Chem. 278, 10201–10207 (2003).
Modery, C. L. et al. Heteromultivalent liposomal nanoconstructs for enhanced targeting and shear-stable binding to active platelets for site-selective vascular drug delivery. Biomaterials 32, 9504–9514 (2011).
Daley, J. M. et al. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J. Leukoc. Biol. 83, 64–70 (2008).
Elliott, J. T. & Prestwich, G. D. Maleimide-functionalized lipids that anchor polypeptides to lipid bilayers and membranes. Bioconjug. Chem. 11, 832–841 (2000).
Zhang, H. Thin-film hydration followed by extrusion method for liposome preparation. Methods Mol. Biol. 1522, 17–22 (2017).
Hope, M. J. et al. Reduction of liposome size and preparation of unilamellar vesicles by extrusion techniques. Liposome Technol. 1, 123–139 (1993).
Bennewitz, M. F. et al. Lung vaso-occlusion in sickle cell disease mediated by arteriolar neutrophil-platelet microemboli. JCI Insight 2, e89761 (2017).
von Bruhl, M. L. et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J. Exp. Med. 209, 819–835 (2012).
Martinod, K. et al. Neutrophil histone modification by peptidylarginine deiminase 4 is critical for deep vein thrombosis in mice. Proc. Natl Acad. Sci. USA 110, 8674–8679 (2013).
Middleton, E. A. et al. Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood 136, 1169–1179 (2020).
Lehmann, M. et al. Platelets drive thrombus propagation in a hematocrit and glycoprotein VI–dependent manner in an in vitro venous thrombosis model. Arterioscler. Thromb. Vasc. Biol. 38, 1052–1062 (2018).
Ramacciotti, E. et al. Evaluation of soluble P-selectin as a marker for the diagnosis of deep venous thrombosis. Clin. Appl. Thromb. Hemost. 17, 425–431 (2011).
Dyer, M. R. et al. Platelet-derived extracellular vesicles released after trauma promote hemostasis and contribute to DVT in mice. J. Thromb. Haemost. 17, 1733–1745 (2019).
Bhattacharya, A. et al. Autophagy is required for neutrophil-mediated inflammation. Cell Rep. 12, 1731–1739 (2015).
Melles, R. B. & Marmor, M. F. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy. JAMA Ophthalmol. 132, 1453–1460 (2014).
Mercuro, N. J. et al. Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19). JAMA Cardiol. 9, 1036–1041 (2020).
Sames, E., Paterson, H. & Li, C. Hydroxychloroquine-induced agranulocytosis in a patient with long-term rheumatoid arthritis. Eur. J. Rheumatol. 3, 91–92 (2016).
Castanheira, F. V. S. & Kubes, P. Neutrophils and NETs in modulating acute and chronic inflammation. Blood 133, 2178–2185 (2019).
Silvestre-Roig, C. et al. Neutrophil diversity in health and disease. Trends Immunol. 40, 565–583 (2019).
Djie, M. Z., Stone, S. R. & Le Bonniec, B. F. Intrinsic specificity of the reactive site loop of α1-antitrypsin, α1-antichymotrypsin, antithrombin III, and protease nexin I. J. Biol. Chem. 272, 16268–16273 (1997).
Peiser, L., Mukhopadhyay, S. & Gordon, S. Scavenger receptors in innate immunity. Curr. Opin. Immunol. 14, 123–128 (2002).
Lahoz-Beneytez, J. et al. Human neutrophil kinetics: modeling of stable isotope labeling data supports short blood neutrophil half-lives. Blood 127, 3431–3438 (2016).
Bulbake, U. et al. Liposomal formulations in clinical use: an updated review. Pharmaceutics 9, 12 (2017).
Branzk, N. et al. Neutrophils sense microbe size and selectively release neutrophil extracellular traps in response to large pathogens. Nat. Immunol. 15, 1017–1025 (2014).
Pawlowski, C. L. et al. Platelet microparticle-inspired clot-responsive nanomedicine for targeted fibrinolysis. Biomaterials 128, 94–108 (2017).
Stavrou, E. X. et al. Factor XII and uPAR upregulate neutrophil functions to influence wound healing. J. Clin. Invest. 128, 944–959 (2018).
Stavrou, E. X. et al. Host and tumor factor XII drive ovarian cancer maintenance and progression. Blood 134, 2384–2384 (2019).
Englert, H. et al. Defective NET clearance contributes to sustained FXII activation in COVID-19-associated pulmonary thrombo-inflammation. EBioMedicine 67, 103382 (2021).
